Garden Grove, CA—Alkemist Labs has once again been accredited to the requirements of ISO/IEC 17025:2017 from the American Association for Laboratory Accreditation (AALA), according to a press release. The accreditation has been renewed until February 28, 2022.
The accreditation demonstrates that Alkemist Labs meets technical and quality benchmarks as required by ISO/IEC 17025:2017. The company is now accredited to perform tests within their scope on dietary supplements, crude plant matter, plant extracts, oils, raw materials, finished products, fungal and algal species, and cannabis.
The accreditation process assessed the lab’s quality management system and competence to perform Dietary Supplement Identification and Qualitative Analysis HPTLC testing and Botanical Identification and Qualitative Analysis by Microscopy, the release says. Alkemist’s internally developed cannabinoids and terpenes assays were also included in the scope of the accreditation.
Related: The Latest in Independent Testing
AHPA’s Cannabis Committee Celebrates 10th Anniversary
Alkemist Labs Warns of Falsified Lab Reports
“Having the CBD method and the new terpenes method included in this most recent accreditation further solidifies our standing as a hemp testing authority,” said Elan Sudberg, CEO of Alkemist Labs, in the press release. “And it’s important to note that the identification portion of the testing scope meets the A2LA P112 Flexible Scope Policy, confirming our ability to give accurate results without delay for some complicated material.”
“Alkemist Labs was one of the first cannabis testing laboratories accredited by A2LA back in 2015, demonstrating their dedication to quality testing in this evolving industry,” added Chris Gunning, AALA General Manager of Accreditation Services. “We are pleased to see them expanding their capabilities to greater serve the needs of the market in California.”